Today: 7 November 2025
Subscribe
Commerzbank Q3 2025: Profit Misses Forecasts as Tax Bill Bites, But NII Outlook Rises and 9‑Month Operating Result Hits Record Amid UniCredit Pressure
 ·  ·  ·  · 

Commerzbank Q3 2025: Profit Misses Forecasts as Tax Bill Bites, But NII Outlook Rises and 9‑Month Operating Result Hits Record Amid UniCredit Pressure

by
7 November 2025

FRANKFURT — November 7, 2025. Commerzbank’s third‑quarter headline profit came in weaker than expected, but the bank raised its 2025 net interest income (NII) guidance and posted a record operating result for the first nine months—underlining CEO Bettina Orlopp’s push to keep the lender independent as Italy’s UniCredit builds its stake. [1]

What happened in Q3 2025

Commerzbank reported €591 million in net profit for the quarter ended Sept. 30, down 7.9% year on year and below a €659 million consensus, largely because the effective tax rate jumped to 36% from 22% a year earlier and operating costs rose around 5%. Shares fell more than 3% after the release. [2]

Behind that accounting drag, operating performance remained robust. The operating result rose 18% year on year to €1.047 billion in Q3, helping lift the nine‑month operating result to a record €3.442 billion (up 21%). Nine‑month revenues climbed 11% to €9.0 billion, with Q3 revenues at €2.9 billion; net commission income increased 7% in Q3 to €985 million, while NII was stable at roughly €2.0 billion in the quarter and €6.2 billion year‑to‑date. [3]

Guidance and shareholder returns

Management confirmed its 2025 profit target of about €2.9 billionbefore restructuring costs (around €2.5 billion after), and raised the 2025 NII outlook to ~€8.2 billion from ~€8.0 billion. The capital return plan continues: a €1 billion buyback launched on Sept. 25 and the bank has applied for an additional buyback of up to €600 million, subject to regulatory approvals and the German Finance Agency. [4]

Commerzbank ended the period with a CET1 ratio of 14.7%, a cost‑income ratio of 56% after nine months (better than the ~57% full‑year target), and a net RoTE of 10% before restructuring expenses. The bank reiterated that 2025 results remain sensitive to developments related to Russia and legal risks in mBank’s foreign‑currency mortgage portfolio. [5]

Under the hood: where growth is (and isn’t)

  • Corporate clients: Average loan volumes rose 13% year on year to €113 billion, contributing to higher interest income and a stronger operating contribution. [6]
  • Retail/SME at home: Loan volumes were broadly flat around €125 billion; deposits averaged €176 billion in Q3. That mix helped NII resilience but points to a slower growth lane on the domestic retail side. WirtschaftsWoche captured this tension as a “hidden growth problem”—strong earnings today, but a need to convert that into sustained volume growth beyond rate tailwinds. [7]

Orlopp’s record run meets first earnings miss

The FAZ noted that Q3 marked the first time under CEO Bettina Orlopp that Commerzbank missed profit expectations—despite a powerful start to the year and a nine‑month net result of €1.9 billion. The quarterly shortfall was driven primarily by the higher tax rate rather than weakening operations. [8]

Orlopp, who became CEO in October 2024 after serving as CFO, has pushed efficiency and digitisation while keeping discipline on risk. BILD highlighted the bank’s “best nine‑month result ever” under her tenure and the drive for savings, including previously announced staffing measures. [9]

UniCredit’s creeping stake—and the independence question

The backdrop to every Commerzbank print in 2025 is UniCredit’s accumulation of shares. The Italian bank has built a stake of roughly 26% and received ECB clearance to go up to 29.9%; crossing 30% would trigger a mandatory takeover bid under German rules. Berlin has signalled coolness toward a deal, and Commerzbank’s board and works council have emphasised a stand‑alone strategy. [10]

Strategy check: “Momentum” targets to 2028

Commerzbank’s “Momentum” plan targets by 2028 a ~50% cost‑income ratio, ~15% net RoTE, and ~100% payout of net profit (dividends plus buybacks), contingent on capital and regulatory conditions. Management says the bank is tracking ahead of plan on efficiency and fee growth. The risk result stayed moderate (–€515 million for the first nine months) with an NPE ratio of 1.0%. [11]

Key numbers at a glance

  • Q3 2025 net profit:€591m (–7.9% YoY) vs consensus €659m; tax rate 36% (22% a year ago). [12]
  • Q3 operating result:€1.047bn; 9M operating result:€3.442bn (record; +21% YoY). [13]
  • 2025 NII guidance:~€8.2bn (raised from ~€8.0bn). [14]
  • Capital & efficiency:CET1 14.7%; C/I 56% after nine months; Net RoTE 10% (pre‑restructuring). [15]
  • Shareholder returns:€1bn buyback in market; up to €600m additional buyback application filed. [16]

Why it matters today (Nov. 7)

For markets, the mild miss and higher tax profile are near‑term noise; the raised NII and record operating momentum are the signal. For strategy, the combination of organic growth (notably in corporate lending), capital returns, and political resistance to a cross‑border takeover will be read as a fresh argument for keeping Commerzbank independent—exactly what Orlopp has been telegraphing. [17]

What to watch next

  1. Rate path & NII sensitivity: If euro‑area rates fall faster than expected, can higher fee income and lending volumes offset NII pressure? [18]
  2. Regulatory outcomes: Progress on approvals connected to the additional €600m buyback and any changes in UniCredit’s 29.9% cap strategy. [19]
  3. mBank legacy risks: Trajectory of FX‑mortgage litigation costs and provisioning. [20]
  4. Execution on “Momentum”: Delivery toward C/I ~50% and RoTE ~15% by 2028, including ongoing personnel measures. [21]

Context & reporting notes for Nov. 7, 2025

  • FAZ emphasised that Q3 was the first expectations miss under Orlopp, even as year‑to‑date profit holds steady. [22]
  • BILD framed Orlopp as the “billion‑maker,” underlining the record nine‑month performance and cost discipline since her promotion in October 2024. [23]
  • Commerzbank’s own release details the record 9M operating result, higher NII outlook, buybacks, and capital and risk metrics cited above. [24]
  • Reuters and the WSJ captured the market reaction, miss vs consensus, and the raised NII guidance. [25]
  • The UniCredit stake‑building remains the strategic overhang, with ECB approval to 29.9% and Berlin’s persistent scepticism about a deal. [26]

This article was prepared for publication on November 7, 2025, and synthesises the bank’s Q3 2025 figures, official guidance, and same‑day/overnight reporting from major outlets and the company.

Was wäre aus 1.000 € geworden, wenn du vor 10 Jahren in #commerzbank investiert hättest?📈 #aktien
Watch this video on YouTube.

References

1. www.reuters.com, 2. www.reuters.com, 3. www.commerzbank.de, 4. www.commerzbank.de, 5. www.commerzbank.de, 6. www.commerzbank.de, 7. www.commerzbank.de, 8. www.faz.net, 9. www.bild.de, 10. www.reuters.com, 11. www.commerzbank.de, 12. www.reuters.com, 13. www.commerzbank.de, 14. www.wsj.com, 15. www.commerzbank.de, 16. www.commerzbank.de, 17. www.reuters.com, 18. www.wsj.com, 19. www.commerzbank.de, 20. www.commerzbank.de, 21. www.commerzbank.de, 22. www.faz.net, 23. www.bild.de, 24. www.commerzbank.de, 25. www.reuters.com, 26. www.ft.com

Tags:

Marcin Frąckiewicz Latest posts

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

  1. Comet 3I/ATLAS Today (Nov 7, 2025): New Mars‑orbiter images, how to see it before dawn, and what scientists are learning about this interstellar visitor
  2. TSMC (TSM) Pre‑Market Briefing, Nov 7, 2025: Jensen Huang Visits Taiwan Partner, Taiwan Exports Soar on AI Demand, and 2026 Price‑Hike Reports Surface
  3. Berkshire Hathaway (BRK.A) Before the Bell — What to Know on Nov. 7, 2025
  4. Meta Platforms (META) Pre‑Market Update Today — November 7, 2025: Reuters scam‑ads bombshell, fresh AI‑training lawsuit, and what it means for the stock

Stock Market Today

  • JPMorgan: Bitcoin Cheap Relative to Gold Amid Market Pullback
    November 7, 2025, 11:52 AM EST. JPMorgan argues Bitcoin is now undervalued vs. gold after a broad market pullback. The report notes BTC slipped under $102,000 as stocks wobbled on weak labor data and rising debt, while U.S. spot BTC ETFs endured nearly $900 million in outflows in three days. Lead strategist Nikolaos Panigirtzoglou says Bitcoin is about $68,000 too low vs. gold-a reversal from last year's roughly $36,000 excess. If macro conditions hold, the relative discount could attract institutional buyers. Traders also watch a $100,000 support level and Fed expectations, with CME FedWatch pricing roughly 69% odds of a 0.25% cut in December. ETF flows and sentiment remain sensitive to macro signals.
  • Money Markets in Strain as Reserves Tighten and Rates Rise
    November 7, 2025, 11:50 AM EST. Rising pressure in money markets is centered on tightening reserves as the Fed balance sheet reduction and increased T-bill issuance push spreads wider. The Treasury General Account has grown due to delayed spending, draining liquidity from banks and leaving funding markets with stiffer competition for cash. As a result, SOFR and TGCR are trading above the IORB. Money-market funds have shifted from the Fed's reverse repo facility to higher-yield assets, and year-end balance-sheet constraints add to the strain. The takeaway: reserves may be nearing adequacy, and ongoing rate volatility in funding markets could spill into credit markets.
  • ANI Pharmaceuticals (ANIP) Q3 Earnings Beat Estimates: EPS $2.04, Revenue $227.81M
    November 7, 2025, 11:44 AM EST. ANI Pharmaceuticals (ANIP) reported Q3 results with EPS of $2.04, topping the Zacks Consensus Estimate of $1.74 and up from $1.34 a year ago. The quarter's figures are adjusted for non-recurring items. Revenue reached $227.81 million, beating the consensus by 7.81% versus $148.33 million a year earlier. ANI has surpassed estimates in four straight quarters. Year-to-date, the stock has advanced about 63.2% versus the S&P 500's 14.3% gain. Ahead of the call, the Zacks Rank remains #2 (Buy), with expectations for the next quarter of $2.05 in EPS on $225.92 million in revenue, and $7.29 on $845.72 million for the year. Industry outlook in Medical - Biomedical and Genetics could influence further moves.
  • Dow Jones Today: Tech-Sector Weakness Pressures Major Averages as Tesla Dips on Musk Pay Plan
    November 7, 2025, 11:40 AM EST. U.S. stocks slipped in early trading as cooling AI sentiment weighed on tech shares, sending the Nasdaq down about 1.3%, the S&P 500 around -0.7%, and the Dow near -0.5%. After a sharp Wednesday session, markets signaled weekly losses amid pressure from chipmakers and large-cap tech names. Tesla shares fell roughly 3% after investors approved a controversial $1 trillion pay package tied to ambitious performance goals. Nvidia and Alphabet slipped, while Amazon, Meta, and Apple were modestly lower; Microsoft edged higher. The broader market awaited a delayed October jobs report due to the government shutdown, with private data suggesting ongoing labor-market softness and continued expectations for a third Federal Reserve rate cut this year in December. Treasuries held near 4.1%, gold firmed, oil higher, and bitcoin hovered near $100,000.
  • Wendy's Q3 Earnings Beat Estimates but Zacks Rank Signals Near-Term Pressure
    November 7, 2025, 11:38 AM EST. Wendy's (WEN) reported Q3 earnings of $0.24 per share, topping the Zacks Consensus of $0.20 and down from $0.25 a year ago. Revenue came in at $549.52 million, beating the street by 2.37%. Over the last four quarters, the company has surpassed EPS estimates three times. Despite the beat, the stock has fallen about 45.8% this year while the S&P 500 rose. The article notes an outlook of unfavorable estimate revisions and assigns a Zacks Rank #5 (Strong Sell), implying near-term underperformance. Looking ahead, the current consensus for the coming quarter is $0.18 on $533.84 million in revenue, with full-year estimates at $0.86 on $2.15 billion. Industry conditions in Retail - Restaurants remain a headwind.
Navitas (NVTS) Stock Skyrockets on NVIDIA AI Chip News — Record Rally Sparks Bull-Bear Debate
Previous Story

Navitas Semiconductor (NVTS) slides as CFO offloads ~$1M in stock; Q3 2025 prints steep losses while ‘Navitas 2.0’ pivots to high‑power AI and grid markets (Nov 7, 2025)

Shenzhou‑20: China Delays Astronauts’ Return After Suspected Space‑Debris Strike — Latest on Tiangong (Nov 7, 2025)
Next Story

Shenzhou‑20: China Delays Astronauts’ Return After Suspected Space‑Debris Strike — Latest on Tiangong (Nov 7, 2025)

Related Articles

Go toTop